Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement

Claudia A Martinez; Brian O'Neill; Vikas Singh; William W O'Neill

doi:10.1002/ccd.24678

Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E587-91. doi: 10.1002/ccd.24678. Epub 2013 Mar 25.

Authors

Claudia A Martinez¹, Brian O'Neill, Vikas Singh, William W O'Neill

Affiliation

¹ Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miller School of Medicine, Miami, Florida.

PMID: 23008182
DOI: 10.1002/ccd.24678

Abstract

In the era of transcatheter aortic valve therapies, the presence of residual paravalvular regurgitation (PVR) after transcatheter aortic valve replacement (TAVR) may become a clinical challenge. Management of late symptomatic PVR is still unknown. We describe a challenging case of percutaneous closure attempt of a clinically significant PVR in a patient after Edwards SAPIEN (Edwards Lifesciences, CA) TAVR.

Keywords: Edwards SAPIEN and paravalvular regurgitation; aortic stenosis; transcatheter aortic valve replacement.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Aortic Valve Insufficiency / diagnosis
Aortic Valve Insufficiency / etiology
Aortic Valve Insufficiency / therapy*
Aortic Valve Stenosis / diagnosis
Aortic Valve Stenosis / therapy*
Cardiac Catheterization / adverse effects*
Cardiac Catheterization / instrumentation
Echocardiography, Doppler, Color
Echocardiography, Transesophageal
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation / adverse effects*
Heart Valve Prosthesis Implantation / instrumentation
Heart Valve Prosthesis Implantation / methods
Humans
Male
Radiography, Interventional
Septal Occluder Device
Severity of Illness Index
Treatment Outcome